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1. Introduction
  West Nile virus (WNV) is a member of Flaviviridae family, 
genus Flavivirusthat includes small and enveloped viruses. WNV 
is found in Africa, Eurasia, Australia, and North America. The 
genome of the virus is a single-stranded, positive sense RNA by 
approximately 11 000 bp in length[1,2].  WNV is a mosquito-borne 
virus that infects various mammal species specially horses and 
humans[3]; however, the most commonly WNV infected animals are 
birds that serves as the reservoir host[2,4].
  The main mode of WNV transmission is by the bite of an infected 
mosquito. Other transmission routes in humans include blood 
transfusion ,organ transplantation, breastfeeding and even during 
pregnancy from mother to baby that are less common[5]. The 
majority of infected people with the virus (approximately 80%), 
have no symptoms and up to 20 percent of them have mild flu-like 
symptoms, such as muscle aches and a fever. Serious symptoms are 
mostly included encephalitis and meningitis that occur in about one 
in 150 infected people with WNV[6]. Till now, several studies in Iran 
have been discussed aboutthe seroprevalence of WNV[7]; however, 
the prevalence of the virus in recent years has not been studied in 
Mashhad city. The aim of this study was to determine the WNV 
prevalence in Mashhad, Northeast of Iran.
2. Materials and methods
2.1. Sampling 
  In this study, 182 individuals were employed from March 2011 
to March 2012. Multistage Cluster Sampling method was applied 
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to determine the prevalence of WN among selected population[8]. 
Samples were collected in different seasons. Number of collected 
samples in spring, summer, autumn and winter were 50, 40, 45 and 
47, respectively. Following registration of 182, informed consent 
was obtained and a questionnaire was filled for each participant. Five 
milliliter of venous blood was obtained and the sera were collected. 
The prevalence of anti-WNV, both IgM and IgG, was determined by 
ELISA method. 
2.2. IgG detection
  For IgG ELISA, wells were coated overnight at 4 曟 with mouse 
hyperimmuneascitic fluid diluted 1:1 000 in 0.05% Tween-20 PBS 
containing 5% skim milk as a saturating reagent. Antigen and sera 
were diluted by this solution. Native antigen at 1:500 dilution was 
incubated for 1 h at 37 曟 and after washing with 0.05% Tween-20 
PBS, human samples diluted 1:100 was added and incubated for 1 h 
at 37 曟. Peroxidase labeled anti-human immunoglobulin was added 
at 1:1 000 for 1 h at 37 曟. After 10 min incubation with 3,3’,5,5’-
tetramethylbenzidine (TMB) substrate (KPL, USA), the OD was 
read at 450 and 620 nm. 
2.3. IgM detection
  For IgM ELISA, the ELISA plates were coated with goat IgG 
fraction to human IgM (anti-M chain) diluted in PBS r1 and 
incubated overnight at 4 曟. After addition of diluted native antigen, 
diluted immunoascite was then added. After a definite incubation, 
peroxidase-labelled anti-mouse immunoglobulin was added and 
incubated. The plates were then washed three times with PBST 
containing 0.5% Tween. Finally, hydrogen peroxide and TMB were 
added and after a short incubation, the enzymatic reaction was 
stopped by the addition of 4 N sulphuricacid. The plates were then 
read by an ELISA reader at 450 nm[5].
3. Results
  Of 182 participants, 136 (74.7%) were female and 46 (25.3%) were 
male. The age range was from 15 to 65 years and themean of age 
was 36.8 years. None of them were found to be positive for WNV 
IgM antibody by ELISA. The overall prevalence of positive WNV 
IgG antibody was 11.0% (20 out of 182 participants) using ELISA 
method, which included 13 female (7.1%) and 7 male (3.8%). The 
association between WNV IgG antibody positivity and gender was 
not statistically significant (P =0.289). The prevalence of antibodies 
against WNV was not similar in different age groups and it was not 
statistically significant (P =0.527).  The highest prevalence rate was 
14.5% in the age group 31-45 years (Figure 1).
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Figure 1. Frequency of WNV IgG antibody according to the age groups.
  The highest prevalence of WNV IgG antibody was observed in 
collected samples during spring (Figure 2); however, there was no 
statistically significant association between WNV IgG antibody 
positivity and the season of sample collection (P =0.831).  
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Figure 2. Frequency of WNV IgG antibody according to the season of 
sample collection.  
4. Discussion
  WNV is an arbovirus that is found in temperate and tropical 
regions of the world. The most WNV infections are asymptomatic. 
The incubation period is 3-15 days and the symptoms of the WNV 
disease are fever, malaise, myalgia, fatigue, vomiting, diarrhea, skin 
rash and lymphadenopathy[3]. In some patients,the virus can cause a 
potentially serious illness with severe symptoms including West Nile 
meningitis, West Nile encephalitis, and acute flaccid paralysis[9, 10]. 
  The virus is widely distributed in different parts of world 
including Africa, Asia, Middle East and Europe[11, 12]. Previous 
seroepidemiology studies in Iran demonstrated that the presence 
of WNV antibody in different regions of Iran[7, 13-15].  Since, 
there is currently no specific antiviral therapy for the treatment of 
WNV infection and no effective vaccine for prevention, on-going 
monitoring and surveillance studies regarding WNV prevalence is 
an important broadcasting tool for health care authorities to have 
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a prospective concerning this life-threatening arbovirus in order to 
choose the best preventive strategies.
  In this study, 182 participants who were residents of Mashhad city, 
WNV IgM and IgG seroprevalencewere determined by ELISA. 
Accordingly, the prevalence of WNV IgG antibody was 11.0 %.  
  In a previous study in 2010, the prevalence of WNV among blood 
donors in Tehran city, which was determined by ELISA method for 
anti -WNV IgG, was 5%, while all samples were negative for WNV-
specific IgM antibody at the time of the study[15]. In another study, 
1976, the prevalence of antibody against WNV was reported to range 
between 0.0% among people living in Tabriz (urban area of East 
Azerbaijan province)  to 95.8% among people living in Deiqi (rural 
area of Khozestan province) of Iran[7]. In this study, the prevalence 
of WNV in Mashhad was reported 2% by virus neutralization 
test[7] that is lower than our study. The differences may be due to 
the different times of sampling. Also, climate change due to global 
warming in recent years may increase mosquito activity period that 
consequently can lead to escalating virus prevalence[16].
  To sum up, because of climate differences in Iran, the distribution 
and abundance of mosquito varies in different provinces of Iran. 
Accordingly, those provinces with warmer climate and longer 
period for mosquito activity may show higher prevalence of 
WNV infection[17, 18]. Seroepidemiological studies are essential to 
determine the prevalence of WNV in other parts of Iran especially in 
endemic area for better decision making in the future.
To sum up, this study demonstrates that the prevalence of WNV 
is considerable in Mashhad city, Iran. It can be claimed that 
continues surveillance is essential to monitor the prevalence of 
WNV infectionsand also in hospitalized patients with encephalitis 
and meningitis. In addition, community-based mosquito control 
programs play a critical role in the elimination of WNV infection[19].
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